WHO Approves Trials for Two New Ebola Vaccines Targeting Bundibugyo Strain

The World Health Organization has approved clinical trials for two new Ebola vaccines designed for the Bundibugyo strain, which has no approved vaccine or treatment. The candidates are ChAdOx1, from Oxford University and the Serum Institute of India, and Moderna's mRNA-1469. Both are expected to join an existing trial in the Democratic Republic of the Congo.